Gastrointestinal Stromal Tumors (GISTs) Treatment Market Report

Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 25, 2022
  • PAGES：235
  • REPORT CODE：GMM1406188
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine.

    This report elaborates on the current development of the Gastrointestinal Stromal Tumors (GISTs) Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Immunicum

    • Natco Pharma

    • Novartis

    • Roche

    • Boston Biomedical

    • Arog Pharmaceuticals

    • Sun Pharmaceutical

    • Bayer

    • Pfizer

    • AB Science

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Surgery

    • Targeted Therapy

    • Radiation Therapy

    • Chemotherapy

    • Ablation

    • Embolization

    • Others

    Application:

    • Hospitals

    • Clinics

    • Ambulatory Surgical Centers

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Overview

      • 1.1.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Scope and Market Segments

      • 1.1.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Characteristics

      • 1.1.3 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Surgery

      • 1.2.2 Targeted Therapy

      • 1.2.3 Radiation Therapy

      • 1.2.4 Chemotherapy

      • 1.2.5 Ablation

      • 1.2.6 Embolization

      • 1.2.7 Others

    • 1.3 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospitals

      • 1.3.2 Clinics

      • 1.3.3 Ambulatory Surgical Centers

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry PEST Analysis

    • 2.3 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Gastrointestinal Stromal Tumors (GISTs) Treatment Industry

    Chapter 3 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Manufacturer

    • 3.1 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Top 3 Players

    Chapter 4 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Type (2017-2028)

    • 4.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Market Trend, by Type

    • 4.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Gastrointestinal Stromal Tumors (GISTs) Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis

    • 7.1 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Type

    • 7.2 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Application

    • 7.3 North America Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis

    • 8.1 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Type

    • 8.2 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Application

    • 8.3 Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis

    • 9.1 APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Type

    • 9.2 APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Application

    • 9.3 APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Company Profiles

      • 11.1 Immunicum

        • 11.1.1 Immunicum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.1.3 Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Natco Pharma

        • 11.2.1 Natco Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.2.3 Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Novartis

        • 11.3.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.3.3 Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Roche

        • 11.4.1 Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.4.3 Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 Boston Biomedical

        • 11.5.1 Boston Biomedical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 Boston Biomedical Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.5.3 Boston Biomedical Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Arog Pharmaceuticals

        • 11.6.1 Arog Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.6.3 Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Sun Pharmaceutical

        • 11.7.1 Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.7.3 Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Bayer

        • 11.8.1 Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.8.3 Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Pfizer

        • 11.9.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.9.3 Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 AB Science

        • 11.10.1 AB Science Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Product Profiles, Application and Specification

        • 11.10.3 AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Gastrointestinal Stromal Tumors (GISTs) Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Surgery (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Targeted Therapy (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Radiation Therapy (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Chemotherapy (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Ablation (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Embolization (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Others (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Hospitals (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Clinics (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Ambulatory Surgical Centers (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Gastrointestinal Stromal Tumors (GISTs) Treatment Market Share, by Manufacturer in 2022

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Type (2017-2028)

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value, by Type (2017-2028)

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Price Trend, by Type (2017-2028)

    • Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Type (2017-2028)

    • Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value, by Type (2017-2028)

    • Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Price Trend, by Type (2017-2028)

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Application (2017-2028)

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value, by Application (2017-2028)

    • Table Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value Share, by Application (2017-2028)

    • Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Application (2017-2028)

    • Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value, by Application (2017-2028)

    • Table China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Type (2017-2028)

    • Table North America Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Application (2017-2028)

    • Table North America Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Value and Growth Rate (2017-2028)

    • Table Immunicum Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Immunicum Product Profiles, Application and Specification

    • Table Immunicum Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Natco Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Natco Pharma Product Profiles, Application and Specification

    • Table Natco Pharma Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis Product Profiles, Application and Specification

    • Table Novartis Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Roche Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Roche Product Profiles, Application and Specification

    • Table Roche Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boston Biomedical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boston Biomedical Product Profiles, Application and Specification

    • Table Boston Biomedical Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Arog Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Arog Pharmaceuticals Product Profiles, Application and Specification

    • Table Arog Pharmaceuticals Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sun Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sun Pharmaceutical Product Profiles, Application and Specification

    • Table Sun Pharmaceutical Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Bayer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Bayer Product Profiles, Application and Specification

    • Table Bayer Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AB Science Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AB Science Product Profiles, Application and Specification

    • Table AB Science Gastrointestinal Stromal Tumors (GISTs) Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US